Rep. Julie Johnson Unloads The Cigna Group (NYSE:CI) Shares

Representative Julie Johnson (D-Texas) recently sold shares of The Cigna Group (NYSE:CI). In a filing disclosed on April 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in The Cigna Group stock on March 3rd. The trade occurred in the Representative’s “MERRILL LYNCH LONG TERM GROWTH” account.

Representative Julie Johnson also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 3/21/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/19/2025.
• Purchased $1,001 – $15,000 in shares of The Cigna Group (NYSE:CI) on 3/19/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/14/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/12/2025.
• Purchased $1,001 – $15,000 in shares of 3M (NYSE:MMM) on 3/12/2025.
• Sold $1,001 – $15,000 in shares of Webster Financial (NYSE:WBS) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Sonos (NASDAQ:SONO) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Teradyne (NASDAQ:TER) on 3/3/2025.

The Cigna Group Trading Up 0.2 %

Shares of CI stock traded up $0.53 during trading hours on Thursday, hitting $329.97. 2,847,261 shares of the company’s stock traded hands, compared to its average volume of 1,691,454. The stock has a market cap of $90.30 billion, a PE ratio of 26.96, a price-to-earnings-growth ratio of 0.98 and a beta of 0.51. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The stock’s 50 day simple moving average is $314.43 and its 200 day simple moving average is $311.19. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company earned $6.79 EPS. On average, sell-side analysts anticipate that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.83%. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group’s dividend payout ratio (DPR) is presently 49.35%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Mizuho upped their price target on shares of The Cigna Group from $360.00 to $384.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Morgan Stanley lowered their target price on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Guggenheim initiated coverage on The Cigna Group in a report on Wednesday, April 9th. They set a “buy” rating and a $384.00 price target on the stock. Cantor Fitzgerald raised their price target on shares of The Cigna Group from $350.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, March 20th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $348.00 price target (down from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $373.56.

Insider Transactions at The Cigna Group

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the business’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $310.35, for a total value of $737,391.60. Following the completion of the sale, the director now owns 5,471 shares in the company, valued at approximately $1,697,924.85. The trade was a 30.28 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David Cordani sold 26,527 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the completion of the transaction, the chief executive officer now directly owns 127,767 shares in the company, valued at approximately $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,751 shares of company stock worth $13,603,991. 0.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On The Cigna Group

A number of institutional investors have recently added to or reduced their stakes in CI. Norges Bank bought a new position in shares of The Cigna Group in the fourth quarter worth approximately $867,785,000. T. Rowe Price Investment Management Inc. bought a new position in The Cigna Group in the fourth quarter valued at $724,517,000. GAMMA Investing LLC raised its position in The Cigna Group by 58,799.0% during the first quarter. GAMMA Investing LLC now owns 1,774,626 shares of the health services provider’s stock valued at $583,852,000 after purchasing an additional 1,771,613 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of The Cigna Group during the 4th quarter valued at about $313,911,000. Finally, GQG Partners LLC boosted its stake in The Cigna Group by 22.4% in the fourth quarter. GQG Partners LLC now owns 4,021,582 shares of the health services provider’s stock worth $1,110,520,000 after buying an additional 737,099 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.